Ashton Thomas Private Wealth’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.71M | Buy |
80,185
+2,727
| +4% | +$126K | 0.13% | 174 |
|
|
2025
Q1 | $4.72M | Buy |
77,458
+2,664
| +4% | +$162K | 0.18% | 134 |
|
|
2024
Q4 | $4.23M | Buy |
74,794
+24,314
| +48% | +$1.38M | 0.16% | 147 |
|
|
2024
Q3 | $2.61M | Buy |
50,480
+18,383
| +57% | +$951K | 0.14% | 177 |
|
|
2024
Q2 | $1.33M | Sell |
32,097
-19,210
| -37% | -$798K | 0.07% | 255 |
|
|
2024
Q1 | $2.78M | Buy |
51,307
+14,326
| +39% | +$777K | 0.16% | 160 |
|
|
2023
Q4 | $1.9M | Sell |
36,981
-18,188
| -33% | -$933K | 0.12% | 199 |
|
|
2023
Q3 | $3.2M | Buy |
55,169
+3,518
| +7% | +$204K | 0.23% | 122 |
|
|
2023
Q2 | $3.3M | Buy |
51,651
+3,046
| +6% | +$195K | 0.25% | 108 |
|
|
2023
Q1 | $3.37M | Sell |
48,605
-3,065
| -6% | -$212K | 0.3% | 88 |
|
|
2022
Q4 | $3.72M | Buy |
51,670
+11,074
| +27% | +$797K | 0.37% | 70 |
|
|
2022
Q3 | $2.89M | Buy |
40,596
+10,996
| +37% | +$782K | 0.33% | 88 |
|
|
2022
Q2 | $2.28M | Sell |
29,600
-2,120
| -7% | -$163K | 0.25% | 114 |
|
|
2022
Q1 | $2.32M | Buy |
31,720
+3,427
| +12% | +$250K | 0.2% | 136 |
|
|
2021
Q4 | $1.76M | Buy |
28,293
+24,781
| +706% | +$1.55M | 0.17% | 147 |
|
|
2021
Q3 | $208K | Sell |
3,512
-443
| -11% | -$26.2K | 0.03% | 350 |
|
|
2021
Q2 | $264K | Buy |
3,955
+243
| +7% | +$16.2K | 0.04% | 299 |
|
|
2021
Q1 | $234K | Buy |
3,712
+171
| +5% | +$10.8K | 0.04% | 278 |
|
|
2020
Q4 | $220K | Buy |
+3,541
| New | +$220K | 0.04% | 283 |
|